From 24 to 26 March 2026, the PPRI Africa Network held its second in-person meeting in Johannesburg, South Africa, kindly hosted by the National Department of Health South Africa (NdoH). The meeting marked another important milestone for the network, following its launch at the...
We aim to contribute to affordable, equitable and sustainable access to safe, effective and quality essential medicines in Austria, Europe and globally.
Strengthening collaboration for access to medicines across Africa
GÖG-Colloquium (20 January 2026): Health Economic Thresholds and Reimbursement Decisions for Medicines
How should health systems decide whether the benefits of new medicines are worth the costs? Health economic thresholds are increasingly used to guide reimbursement decisions, yet the basis for these thresholds and their real-world consequences remain the subject of intense debate...
Biosimilar policies: New Evidence from 32 European countries
Experts of the Pharmacoeconomics Department are leading a three-year EU4Health project “Capacity building to support the uptake of biosimilars in a multistakeholder approach” ( AUGMENT Biosimilars). The first year of the AUGMENT Biosimilars project focused on a comprehensive...